Streetbeat News

Earnings

ESPR

Esperion Therapeutics forecasts its FY24 operating expenses to be between $225M-$245M, which includes $20M in non-cash expenses due to stock compensation.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:10 am

TIGO

Millicom Intl Cellular (NASDAQ:TIGO) reported a significant decrease in its quarterly earnings, posting a loss of $(0.37) per share compared to a gain of $0.33 per share in the same period last year, marking a 212.12% decrease.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:09 am

HSIC

Henry Schein anticipates its sales growth for the fiscal year 2024 to range between 8% to 12% over the figures reported in 2023, indicating a positive outlook for the company's financial performance in the upcoming year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:06 am

LOW

Lowe's Companies (NYSE:LOW) reported Q4 earnings of $1.77 per share, surpassing the $1.68 estimate, marking a 5.36% beat and a 12.03% increase from last year. Q4 sales reached $18.60 billion, exceeding the $18.45 billion estimate by 0.82%, despite a 17.12% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:06 am

ESPR

Esperion Therapeutics reported a 44% year-over-year growth in Q4 retail prescription equivalents and projects continued momentum in this segment into the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:06 am

TIGO

Millicom Intl Cellular (NASDAQ:TIGO) reported Q4 sales of $1.48 billion, surpassing the analyst consensus estimate of $1.45 billion by 1.72% and marking a 6.81% increase from $1.38 billion in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:05 am

PRVA

Privia Health Gr (PRVA) reported Q4 2023 adjusted EPS of $0.15, surpassing the $0.04 estimate, but its sales of $440.83M fell short of the $730.89M estimate, marking a 20.97% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:05 am

HSIC

Henry Schein, Inc. (HSIC) has projected its adjusted earnings per share (EPS) for fiscal year 2024 to be in the range of $5.00 to $5.16, aligning closely with the consensus estimate of $5.10.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:05 am

AIRS

AirSculpt Technologies (NASDAQ:AIRS) reported Q4 2023 adjusted EPS of $0.01, missing the $0.02 estimate, and sales of $47.61M, missing the $48.07M estimate. This represents a 16.96% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:04 am

LOW

Lowe's Companies has provided its FY24 outlook, projecting revenues between $84B and $85B, which is below the $85.61B estimate. EPS is expected to be between $12.00 and $12.30, also below the $12.95 estimate. The company anticipates a -2 to -3% decline in comparable sales from the previous year, with an operating margin of 12.6% to 12.7%, interest expenses of about $1.4B, an effective tax rate of 25%, and capital expenditures of around $2B.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:04 am